Clinical Trial Update: Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating etripamil nasal spray for self-administered termination of spontaneous episodes of paroxysmal supraventricular tachycardia. The study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Supraventricular Tachycardia
• Supraventricular Tachycardia

Drugs mentioned

• etripamil nasal spray (etripamil)

Snippet

Sponsor: Corxel Pharmaceuticals | Conditions: Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia | Phase 3 | Status: COMPLETED